Martek to Present at Upcoming Deutsche Bank Conference

COLUMBIA, Md., April 28 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at Deutsche Bank Securities' 33rd Annual Health Care Conference in Boston, MA. The conference is being held May 5 - 7, 2008 at the InterContinental Boston. Martek CEO Steve Dubin will be presenting on Wednesday, May 7th, 2008 at 8:10 a.m. Eastern Time.

A live audio webcast of Martek's presentation can be accessed at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=MATK&item_id=1827532

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.

Contact: Kyle Stults

SOURCE Martek Biosciences Corporation

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.